Liquid biopsies for management of pancreatic cancer (Q57174640)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30118658 AND SRC:MED&resulttype=core&format=json

18 April 2020

title

Liquid biopsies for management of pancreatic cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30118658 AND SRC:MED&resulttype=core&format=json

18 April 2020

1 reference

Armando Del Río Hernández

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30118658 AND SRC:MED&resulttype=core&format=json

18 April 2020

author name string

Mohamadmahdi Samandari

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30118658 AND SRC:MED&resulttype=core&format=json

18 April 2020

María Gil Julia

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30118658 AND SRC:MED&resulttype=core&format=json

18 April 2020

Alistair Rice

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30118658 AND SRC:MED&resulttype=core&format=json

18 April 2020

Antonios Chronopoulos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30118658 AND SRC:MED&resulttype=core&format=json

18 April 2020

language of work or name

English

0 references

publication date

26 July 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30118658 AND SRC:MED&resulttype=core&format=json

18 April 2020

published in

Translational Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30118658 AND SRC:MED&resulttype=core&format=json

18 April 2020

volume

201

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30118658 AND SRC:MED&resulttype=core&format=json

18 April 2020

page(s)

98-127

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30118658 AND SRC:MED&resulttype=core&format=json

Early detection of pancreatic cancer: Where are we now and where are we going?

18 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Deciphering the role of stroma in pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Circulating tumour cells and DNA as liquid biopsies in gastrointestinal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Liquid biopsy: monitoring cancer-genetics in the blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Integrating liquid biopsies into the management of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Exfoliation of membrane ecto-enzymes in the form of micro-vesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Identification of carcinoembryonic antigen mRNA in circulating peripheral blood of pancreatic carcinoma and gastric carcinoma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Liquid biopsies come of age: towards implementation of circulating tumour DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Extracellular vesicles: exosomes, microvesicles, and friends

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

The present and future role of microfluidics in biomedical research.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

ME-PCR for the identification of mutated K-ras in serum and bile of pancreatic cancer patients: an unsatisfactory technique for clinical applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Detection of p53 gene mutations in the supernatant of pancreatic juice and plasma from patients with pancreatic carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Stool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

K-ras mutations in tissue and stool samples from patients with pancreatic cancer and chronic pancreatitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Stool testing for the early detection of pancreatic cancer: rationale and current evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Role of pancreatic cancer-derived exosomes in salivary biomarker development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Salivary MicroRNA in Pancreatic Cancer Patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Salivary HOTAIR and PVT1 as novel biomarkers for early pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Minimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

About the possible origin and mechanism of circulating DNA apoptosis and active DNA release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Origins, structures, and functions of circulating DNA in oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Fragment Length of Circulating Tumor DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Biomarkers for early diagnosis of pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Cell-free nucleic acids as biomarkers in cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Circulating mutant DNA to assess tumor dynamics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Detecting circulating tumor material and digital pathology imaging during pancreatic cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Circulating tumor cells in pancreatic cancer patients: methods of detection and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

En Route to Metastasis: Circulating Tumor Cell Clusters and Epithelial-to-Mesenchymal Transition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

The epithelial to mesenchymal transition in pancreatic cancer: A systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Cancer metastasis through the prism of epithelial-to-mesenchymal transition in circulating tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Involvement of epithelial to mesenchymal transition in the development of pancreatic ductal adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Matrix stiffness induces epithelial-mesenchymal transition and promotes chemoresistance in pancreatic cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

EMT and dissemination precede pancreatic tumor formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Circulating Epithelial Cells in Patients with Pancreatic Lesions: Clinical and Pathologic Findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Detection of circulating pancreas epithelial cells in patients with pancreatic cystic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

High-Throughput Microfluidic Labyrinth for the Label-free Isolation of Circulating Tumor Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Single-cell RNA sequencing identifies extracellular matrix gene expression by pancreatic circulating tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Single-cell mRNA profiling reveals transcriptional heterogeneity among pancreatic circulating tumour cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Saliva exosomes from pancreatic tumor-bearing mice modulate NK cell phenotype and antitumor cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Portal Venous Blood Circulation Supports Immunosuppressive Environment and Pancreatic Cancer Circulating Tumor Cell Activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Aspirin therapy reduces the ability of platelets to promote colon and pancreatic cancer cell proliferation: Implications for the oncoprotein c-MYC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

MINDEC-An Enhanced Negative Depletion Strategy for Circulating Tumour Cell Enrichment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Clinical Significance of Circulating Tumor Microemboli as a Prognostic Marker in Patients with Pancreatic Ductal Adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Circulating tumor cells found in patients with localized and advanced pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Pancreatic Cancer Metastases Harbor Evidence of Polyclonality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Circulating tumor cell clusters: What we know and what we expect (Review).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Pancreatic stellate cells promote epithelial-mesenchymal transition in pancreatic cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Role of pancreatic stellate cells in pancreatic cancer metastasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Pancreatic stellate cells: partners in crime with pancreatic cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Pancreatic stellate cells enhance stem cell-like phenotypes in pancreatic cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

High expression of Galectin‐1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Circulating pancreatic stellate (stromal) cells in pancreatic cancer-a fertile area for novel research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Unexpected gain of function for the scaffolding protein plectin due to mislocalization in pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Wnt5b-associated exosomes promote cancer cell migration and proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Pancreatic cancer-derived exosomes promote tumor metastasis and liver pre-metastatic niche formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Exosomes: extracellular organelles important in intercellular communication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

MicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Exosome-Mediated Intercellular Communication Between Stellate Cells and Cancer Cells in Pancreatic Ductal Adenocarcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Exosomes derived from pancreatic cancer cells induce activation and profibrogenic activities in pancreatic stellate cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Exosomes Derived From Pancreatic Stellate Cells: MicroRNA Signature and Effects on Pancreatic Cancer Cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Pancreatic Cancer-Derived Exosomes Cause Paraneoplastic β-cell Dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Pancreatic cancer-derived exosomes transfer miRNAs to dendritic cells and inhibit RFXAP expression via miR-212-3p

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Pancreatic cancer derived exosomes regulate the expression of TLR4 in dendritic cells via miR-203.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

IP-10/CXCR3 Axis Promotes the Proliferation of Vascular Smooth Muscle Cells through ERK1/2/CREB Signaling Pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Tumour exosome integrins determine organotropic metastasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Combining Machine Learning and Nanofluidic Technology To Diagnose Pancreatic Cancer Using Exosomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Murine and human pancreatic tumor exosome recovery in mouse serum: Diagnostic and prognostic potential and target cell delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Non-coding RNA networks in cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

MicroRNA in pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Noncoding RNAs as novel biomarkers in pancreatic cancer: what do we know?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

MicroRNA in pancreatic ductal adenocarcinoma and its precursor lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Circulating RNAs as new biomarkers for detecting pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Clinical utility of quantitative RT-PCR targeted to alpha1,4-N-acetylglucosaminyltransferase mRNA for detection of pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Clinical significance of serum COL6A3 in pancreatic ductal adenocarcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

The role of miRNAs in the diagnosis, chemoresistance, and prognosis of pancreatic ductal adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

MicroRNA biomarkers in whole blood for detection of pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Plasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Contribution of platelets to tumour metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Platelet extracts induce growth, migration and invasion in human hepatocellular carcinoma in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Exploration of the platelet proteome in patients with early-stage cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Complex role for the immune system in initiation and progression of pancreatic cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

The immune network in pancreatic cancer development and progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Clinical implications of systemic inflammatory response markers as independent prognostic factors for advanced pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: A meta-analysis containing 8252 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Pancreatic Cancer Cell Exosome-Mediated Macrophage Reprogramming and the Role of MicroRNAs 155 and 125b2 Transfection using Nanoparticle Delivery Systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Exosomes and tumor-mediated immune suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Integrated Analysis of Long Non-Coding RNA and mRNA Expression Profile in Pancreatic Cancer Derived Exosomes Treated Dendritic Cells by Microarray Analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Materials and microfluidics: enabling the efficient isolation and analysis of circulating tumour cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Biological Functions and Current Advances in Isolation and Detection Strategies for Exosome Nanovesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Multiparametric plasma EV profiling facilitates diagnosis of pancreatic malignancy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Integrated Analysis of Exosomal Protein Biomarkers on Alternating Current Electrokinetic Chips Enables Rapid Detection of Pancreatic Cancer in Patient Blood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

A signal-amplifiable biochip quantifies extracellular vesicle-associated RNAs for early cancer detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Detection of KRAS Mutations in Circulating Tumor DNA by Digital PCR in Early Stages of Pancreatic Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

A Comparison of Cell-Free DNA Isolation Kits: Isolation and Quantification of Cell-Free DNA in Plasma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Ultrasensitive plasma ctDNA KRAS assay for detection, prognosis, and assessment of therapeutic response in patients with unresectable pancreatic ductal adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Reality of Single Circulating Tumor Cell Sequencing for Molecular Diagnostics in Pancreatic Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Plasma Circulating Tumor DNA in Pancreatic Cancer Patients Is a Prognostic Marker

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Selective identification of somatic mutations in pancreatic cancer cells through a combination of next-generation sequencing of plasma DNA using molecular barcodes and a bioinformatic variant filter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Detection of circulating tumor DNA in early- and late-stage human malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Detection of K-ras gene mutation by liquid biopsy in patients with pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Utility of serum DNA as a marker for KRAS mutations in pancreatic cancer tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

KRAS mutations in blood circulating cell-free DNA: a pancreatic cancer case-control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Targeted deep sequencing of circulating tumor DNA in metastatic pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

K-ras mutational status predicts poor prognosis in unresectable pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Mutant KRAS Circulating Tumor DNA Is an Accurate Tool for Pancreatic Cancer Monitoring.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Circulating tumor cells (Ctc) and kras mutant circulating free Dna (cfdna) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Marker expression in circulating cancer cells of pancreatic cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

A High Circulating Tumor Cell Count in Portal Vein Predicts Liver Metastasis From Periampullary or Pancreatic Cancer: A High Portal Venous CTC Count Predicts Liver Metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Circulating tumour cells-monitoring treatment response in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Isolation of circulating tumor cells in pancreatic cancer patients by immunocytochemical assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Opportunities and Challenges for Pancreatic Circulating Tumor Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

The Potential for Circulating Tumor Cells in Pancreatic Cancer Management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Circulating tumor cell enrichment based on physical properties.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Current detection technologies for circulating tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Automated electrorotation shows electrokinetic separation of pancreatic cancer cells is robust to acquired chemotherapy resistance, serum starvation, and EMT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Isolation of rare circulating tumour cells in cancer patients by microchip technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Modular microsystem for the isolation, enumeration, and phenotyping of circulating tumor cells in patients with pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary result

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Molecular detection of circulating cancer cells during surgery in patients with biliary-pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Carcinoembryonic antigen messenger RNA expression using nested reverse transcription-PCR in the peripheral blood during follow-up period of patients who underwent curative surgery for biliary-pancreatic cancer: longitudinal analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Biological implications of tumor cells in blood and bone marrow of pancreatic cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Expression of cytokeratin 20 in the blood of patients with disseminated carcinoma of the pancreas, colon, stomach, and lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Detection of CK20mRNA in peripheral blood of pancreatic cancer and its clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Detection of tumor cell dissemination in pancreatic ductal carcinoma patients by CK 20 RT-PCR indicates poor survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Detection of disseminated pancreatic cells by amplification of cytokeratin-19 with quantitative RT-PCR in blood, bone marrow and peritoneal lavage of pancreatic carcinoma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Circulating Tumor Cells as a Biomarker in Pancreatic Ductal Adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

KRAS mutations in pancreatic circulating tumor cells: a pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Genetic analysis of circulating tumor cells in pancreatic cancer patients: A pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Cytologic characteristics of circulating epithelioid cells in pancreatic disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Usefulness of circulating tumor cell detection in pancreatic adenocarcinoma diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Multimarker gene analysis of circulating tumor cells in pancreatic cancer patients: a feasibility study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Circulating tumor cells in pancreatic cancer patients: enrichment and cultivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients With Metastatic Pancreatic Adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Portal vein-circulating tumor cells predict liver metastases in patients with resectable pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Extracellular matrix proteins and carcinoembryonic antigen-related cell adhesion molecules characterize pancreatic duct fluid exosomes in patients with pancreatic cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Quantitative Proteomic Analysis of Serum Exosomes from Patients with Locally Advanced Pancreatic Cancer Undergoing Chemoradiotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Glypican-1 identifies cancer exosomes and detects early pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

New insights in the composition of extracellular vesicles from pancreatic cancer cells: implications for biomarkers and functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Nanoplasmonic Quantification of Tumor-derived Extracellular Vesicles in Plasma Microsamples for Diagnosis and Treatment Monitoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

On-chip surface acoustic wave lysis and ion-exchange nanomembrane detection of exosomal RNA for pancreatic cancer study and diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Label-Free Nanoplasmonic-Based Short Noncoding RNA Sensing at Attomolar Concentrations Allows for Quantitative and Highly Specific Assay of MicroRNA-10b in Biological Fluids and Circulating Exosomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Plasma exosome miR-196a and miR-1246 are potential indicators of localized pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Differential methylation of cell-free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Whole genomes redefine the mutational landscape of pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Genomic analyses identify molecular subtypes of pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Diagnosing pancreatic cancer using methylation specific PCR analysis of pancreatic juice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Preproenkephalin hypermethylation in the pure pancreatic juice compared with p53 mutation in the diagnosis of pancreatic carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Cancer detection by ubiquitin carboxyl-terminal esterase L1 methylation in pancreatobiliary fluids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

NPTX2 hypermethylation in pure pancreatic juice predicts pancreatic neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Methylation profile of circulating plasma DNA in patients with pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Road to early detection of pancreatic cancer: Attempts to utilize epigenetic biomarkers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

The new cytogenetics: blurring the boundaries with molecular biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Detection and characterization of putative metastatic precursor cells in cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Capture of viable circulating tumor cells in the liver of colorectal cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Detection and characterization of invasive circulating tumor cells derived from men with metastatic castration-resistant prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

The viable circulating tumor cells with cancer stem cells feature, where is the way out?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Establishment and characterization of a cell line from human circulating colon cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

The early detection of pancreatic cancer: what will it take to diagnose and treat curable pancreatic neoplasia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Sensitive and quantitative detection of KRAS2 gene mutations in pancreatic duct juice differentiates patients with pancreatic cancer from chronic pancreatitis, potential for early detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

KRAS mutations in cell-free DNA from preoperative and postoperative sera as a pancreatic cancer marker: a retrospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Exosomes in cancer: Use them or target them?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Engineering exosomes as refined biological nanoplatforms for drug delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Rethinking liquid biopsy: Microfluidic assays for mobile tumor cells in human body fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Microfluidics for exosome isolation and analysis: enabling liquid biopsy for personalized medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Microfluidic Exosome Analysis toward Liquid Biopsy for Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Integrated immunoisolation and protein analysis of circulating exosomes using microfluidic technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Machine learning to detect signatures of disease in liquid biopsies - a user's guide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Machine Learning-Assisted Network Inference Approach to Identify a New Class of Genes that Coordinate the Functionality of Cancer Networks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Automatic smartphone-based microfluidic biosensor system at the point of care.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

Emerging Technologies for Next-Generation Point-of-Care Testing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2018.07.008

10.1016/J.TRSL.2018.07.008

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30118658 AND SRC:MED&resulttype=core&format=json

18 April 2020

1 reference